Mode
Text Size
Log in / Sign up
N/A Completed N=27 Randomized Double-blind Basic Science

Carbon Dioxide (CO2) and Cognitive Impairment

Healthy
Source: ClinicalTrials.gov NCT05292378 ↗
Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Basal Oxygen Consumption (OCR) — 18.74; 19.54 pmol/min

Summary

The purpose of the study is to better understand the biological mechanisms of carbon dioxide (CO2)-induced cognitive impairments.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Basal Oxygen Consumption (OCR)
18.74; 19.54
PRIMARY
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Total Stimulated Oxygen Consumption.
6.91; 8.95
PRIMARY
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Time to Peak (TTP) Oxygen Consumption
84.48; 67.77

Eligibility Criteria

Inclusion Criteria

  • History of COVID-19 vaccination
  • Weigh at least 110 pounds

Exclusion Criteria

  • Colorblindness
  • Inability to hear verbal instructions
  • Cardiovascular disease, including a history of stroke
  • Diabetes requiring the use of insulin
  • Pregnancy
  • Current asthma (an asthma attack within the past five years)
  • Medications for or history of anxiety disorder diagnosis or panic attacks
  • Medications which may affect cognition such as beta-blockers and CNS depressants

Temporary Exclusion Criteria

  • Respiratory symptoms in the previous four weeks
  • Use of sedating cold/allergy medications in the previous week
  • Use of marijuana in the previous week
  • Consumption of alcohol in the previous 24 hours

Additional Exclusion Criteria for Subjects undergoing the fMRI scan:

  • History of head trauma or neurosurgery or neurological disorder
  • Ferrous metal implanted in or on the body, electrical devices such as a pacemaker, nonremovable ferrous jewelry
  • Surgical pins or plates above the neck
  • History of eye injury involving metallic materials, shavings in eyes, or welding without a face mask
  • Lead or iron tatoos
  • Claustrophobia
  • Back problems that would prevent the subject from laying still comfortably for up to 90 minutes

Additional Exclusion Criteria for Subjects undergoing CAIM

  • Current or recent contact lens use
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05292378). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search